Spruce Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
SPRB chart
What traders are saying about $SPRB
Latest postsSpruce Biosciences, Inc. news
- Spruce Biosciences, Inc. Estimates – NASDAQ:SPRB
TradingView ·
- Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
Yahoo Finance ·
- Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
Yahoo Finance ·
- Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Spruce Biosciences stock gains after analyst backs regulatory progress
investorshub.advfn.com ·
- Spruce Biosciences Announces Launch of MPS3BStudy.com
Yahoo Finance ·
- Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Yahoo Finance ·
- Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Yahoo Finance ·
- Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
Yahoo Finance ·
- Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
Yahoo Finance ·
- Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Yahoo Finance ·
- American Express, Biogen upgraded: Wall Street's top analyst calls
Yahoo Finance ·
Spruce Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $4.9M | $10.1M | $0 |
| Net income | -$39.0M | -$53.0M | -$47.9M | -$46.2M |
| Diluted EPS | $-50.83 | $-96.40 | $-1.24 | $-1.96 |
| Total assets (year end) | $53.0M | $45.2M | $103.9M | $85.6M |
| Cash and equivalents (year end) | $48.9M | $38.8M | $96.3M | $24.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Spruce Biosciences, Inc.
- Ticker
- SPRB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1683553
Frequently asked questions
What exchange is Spruce Biosciences, Inc. listed on?
Spruce Biosciences, Inc. trades on the Nasdaq under the ticker symbol SPRB.
What industry is Spruce Biosciences, Inc. in?
Spruce Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Spruce Biosciences, Inc. headquartered?
Spruce Biosciences, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Spruce Biosciences, Inc.'s fiscal year end?
Spruce Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Spruce Biosciences, Inc. report?
Spruce Biosciences, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.